Czech Republic wants to regulate, rather than ban, synthetic cannabinoids made from CBD

The Ministry of Health of the Czech Republic has announced its decision to regulate, rather than ban, the production of synthetic compounds derived from CBD from hemp, which are likely to generate psychotropic effects. Initially, those responsible for food safety proposed a complete ban on these products. However, the government now intends to establish clear guidelines for its sale and control.

The Czech Parliament is currently considering an amendment proposal that imposes restrictions on substances such as HHC (hexahydrocannabinol) and other synthetic psychoactive products. Key regulations provide that these products are only sold to individuals aged 18 or over, under the supervision of a salesperson (not in vending machines) and with a ban on advertising.

One of the focus areas of the regulation is lab-produced CBD-based compounds that mimic the “high” felt when consuming cannabis. These products are created through laboratory processes that involve CBD and its manipulation, in order to create new compounds. The emergence of HHC initially led to concerns that CBD itself would be banned in the Czech Republic, but the government ended up abandoning this position.

Earlier this year, the Czech Republic was among 20 EU countries where HHC products were readily available, prompting health warnings from the European Monitoring Center for Drugs and Drug Addiction. In March, the Czech government issued warnings about HHC, warning consumers against using these products due to potential health risks.

O Czech Pirate Party (Pirátská Strana), one of the supporters of the proposed amendment, says that a pure and simple ban is not the solution. Instead, they emphasize the need for greater protection for young and adult consumers. Rather than seeking a ban, the focus will be on implementing robust safeguards for users.

As the Czech Republic seeks to strike a balance between regulation and freedom of choice, the proposed amendment aims to ensure the responsible use of synthetic CBD derivatives and other psychoactive substances. With a focus on consumer safety and adherence to clear guidelines, the government hopes to create an environment that protects individuals while allowing informed decisions regarding these products.

____________________________________________________________________________________________________

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

João Xabregas

More postsBiography

With a professional background in CAD technical drawing (2D and 3D), João Xabregas is an activist and advocate for all uses and applications of cannabis. He discovered and entered the world of cannabis during his youth, where he developed a special interest in the cultivation of the plant, which led him on a journey of self-learning through the world of cannabis that continues to this day. His adventures linked to cannabis cultivation began with the same goal as many others: to be able to guarantee the quality and eliminate any possible risks to his health of what he consumed, as well as to avoid any type of dependence on the illicit market. However, he quickly began to view the world of cannabis and everything related to it with a very different perspective. He admits the enormous passion he has for the most persecuted plant in the world and about which he is always willing to write and have a good conversation.

• João Xabregas

  https://cannareporter.eu/author/joaoxabregas/

  Systematic review addresses risks and benefits of medicinal cannabis in mental health
• João Xabregas

  https://cannareporter.eu/author/joaoxabregas/

  South Korea: Researchers identify new cannabinoid 'cannabielsoxa' and discover anti-tumor potential of other cannabinoids in neuroblastoma
• João Xabregas

  https://cannareporter.eu/author/joaoxabregas/

  Germany: CDU MP Christin Christ says cannabis legalization was a “big mistake” and wants to reverse decision
• João Xabregas

  https://cannareporter.eu/author/joaoxabregas/

  European Congress of Psychiatry presents meta-analysis on the benefits of CBD in autism